Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02202746
Title A Study to Assess the Safety and Efficacy of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With FGF Aberrant Metastatic Breast Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Clovis Oncology, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Arizona Oncology Associates Sedona Arizona 86336 United States Details
Comprehensive Blood and Cancer Center Bakersfield California 93309 United States Details
Saint Jude Heritage Medical Center Fullerton California 92835 United States Details
Moores UCSD Cancer Center La Jolla California 92093 United States Details
University of Southern California Los Angeles California 90033 United States Details
Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
University of California, Los Angeles Los Angeles California 90095 United States Details
Cancer Care Associates Medical Group, Inc. Redondo Beach California 90277 United States Details
University of California San Francisco San Francisco California 94115 United States Details
Central Coast Medical Oncology Group Santa Maria California 93454 United States Details
Yale University New Haven Connecticut 06519 United States Details
University of Miami Deerfield Beach Florida 33442 United States Details
Memorial West Cancer Center Hollywood Florida 33021 United States Details
Northwestern University, Robert H. Lurie Comprehensive Cancer Center Chicago Illinois 60611 United States Details
University of Chicago Medical Center Chicago Illinois 60637 United States Details
Indiana University Simon Cancer Center Indianapolis Indiana 46202 United States Details
Horizon Oncology Center Lafayette Indiana 47905 United States Details
The Sidney Kimmel Comprehensive Cancer Center at John Hopkins Baltimore Maryland 21231 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 United States Details
Cooper University Hospital Voorhees New Jersey 08043 United States Details
Sciode Medical Associates, PLLC Bronx New York 10469 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Weill Cornell Breast Center New York New York 10065 United States Details
University Hospitals Case Medical Center Cleveland Ohio 44106 United States Details
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 United States Details
Sarah Cannon Cancer Center Nashville Tennessee 37203 United States Details
Vanderbilt Ingram Cancer Center Nashville Tennessee 37232 United States Details
Texas Oncology - Austin Central Austin Texas 78731 United States Details
Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
The Center for Cancer and Blood Disorders Fort Worth Texas 76104 United States Details
US Oncology Houston Texas 77024 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field